Drug therapies for uterine fibroids: A new approach to an old problem

Research output: Contribution to journalReview articlepeer-review

Abstract

Uterine fibroids are a significant problem in women's health and account for almost 40% of hysterectomies performed annually in the U.S. Until recently, medical treatments focused on drugs that block estrogen production and action. These have had limited success. Now, several novel compounds including selective progesterone receptor modulators and anti-fibrotic drugs such as pirfenidone, halofuginone, and interferons (INFs) are being investigated and show promise for the treatment of these tumors.

Original languageEnglish (US)
Pages (from-to)237-242
Number of pages6
JournalDrug Discovery Today: Therapeutic Strategies
Volume1
Issue number2
DOIs
StatePublished - Oct 2004

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Drug therapies for uterine fibroids: A new approach to an old problem'. Together they form a unique fingerprint.

Cite this